SG29092G - Imidazoquinoline derivatives - Google Patents

Imidazoquinoline derivatives

Info

Publication number
SG29092G
SG29092G SG290/92A SG29092A SG29092G SG 29092 G SG29092 G SG 29092G SG 290/92 A SG290/92 A SG 290/92A SG 29092 A SG29092 A SG 29092A SG 29092 G SG29092 G SG 29092G
Authority
SG
Singapore
Prior art keywords
imidazoquinoline derivatives
imidazoquinoline
derivatives
Prior art date
Application number
SG290/92A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SG29092G publication Critical patent/SG29092G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG290/92A 1985-04-25 1992-03-10 Imidazoquinoline derivatives SG29092G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number Publication Date
SG29092G true SG29092G (en) 1992-05-15

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
SG290/92A SG29092G (en) 1985-04-25 1992-03-10 Imidazoquinoline derivatives

Country Status (32)

Country Link
US (1) US4668686A (de)
KR (1) KR940000828B1 (de)
CN (1) CN1016175B (de)
AT (1) AT390257B (de)
AU (1) AU592983B2 (de)
BE (1) BE904671A (de)
CA (1) CA1298836C (de)
CH (1) CH675722A5 (de)
CY (1) CY1641A (de)
DE (1) DE3614132A1 (de)
DK (3) DK164868C (de)
EG (1) EG18104A (de)
ES (3) ES8708229A1 (de)
FI (1) FI83316C (de)
FR (1) FR2581065B1 (de)
GB (1) GB2174987B (de)
GR (1) GR861086B (de)
HK (1) HK64492A (de)
HU (1) HU195813B (de)
IL (1) IL78581A0 (de)
IT (1) IT1215651B (de)
LU (1) LU86406A1 (de)
MY (1) MY102086A (de)
NL (1) NL8601053A (de)
NO (1) NO163406C (de)
NZ (1) NZ215885A (de)
OA (1) OA08242A (de)
PT (1) PT82460B (de)
SE (1) SE461468B (de)
SG (1) SG29092G (de)
SU (3) SU1450746A3 (de)
YU (1) YU46054B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
JP2007502293A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ含有化合物
EP1658076B1 (de) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy- und arylalkylenoxy-substituierte imidazochinoline
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
BRPI0416936A (pt) 2003-11-25 2007-01-16 3M Innovative Properties Co sistemas de anel de imidazo substituìdos e métodos
EP1701955A1 (de) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl- und arylalkinylsubstituierte imidazochinoline
EP1699788A2 (de) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazochinolinyl-, imidazopyridinyl- und imidazonaphthyridinylsulfonamide
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
EP1846405A2 (de) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxim- und hydroxylaminsubstituierte imidazo-4,5-c-ringverbindungen und verfahren
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
PT2583970E (pt) 2006-08-02 2016-02-08 Cytokinetics Inc Certas entidades químicas, composições e métodos compreendendo imidazopirimidinas
EP2139478A4 (de) * 2007-03-30 2010-05-05 Cytokinetics Inc Bestimmte chemische entitäten, zusammensetzungen und verfahren
EA201791043A1 (ru) 2011-07-13 2017-09-29 Сайтокинетикс, Инк. Комбинированная терапия бокового амиотрофического склероза

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
AU5641386A (en) 1986-10-30
CY1641A (en) 1992-11-06
DK80291A (da) 1991-04-30
IL78581A0 (en) 1986-08-31
LU86406A1 (fr) 1986-11-05
EG18104A (en) 1992-09-30
DE3614132A1 (de) 1986-11-27
DK165248B (da) 1992-10-26
BE904671A (fr) 1986-10-24
FI83316B (fi) 1991-03-15
GR861086B (en) 1986-09-01
DK164868B (da) 1992-08-31
FI861684A (fi) 1986-10-26
SE8601907D0 (sv) 1986-04-24
OA08242A (en) 1987-10-30
HUT42089A (en) 1987-06-29
GB8610037D0 (en) 1986-05-29
HK64492A (en) 1992-09-04
DK165249C (da) 1993-03-22
MY102086A (en) 1992-03-31
CN1016175B (zh) 1992-04-08
NO163406B (no) 1990-02-12
GB2174987B (en) 1989-08-02
FR2581065B1 (fr) 1990-02-02
ES554336A0 (es) 1987-10-01
DK190986A (da) 1986-10-26
PT82460A (en) 1986-05-01
SU1560056A3 (ru) 1990-04-23
NO861617L (no) 1986-10-27
CN86102747A (zh) 1987-02-04
CA1298836C (en) 1992-04-14
GB2174987A (en) 1986-11-19
NZ215885A (en) 1989-04-26
ES557551A0 (es) 1988-02-16
NL8601053A (nl) 1986-11-17
PT82460B (pt) 1988-11-30
AT390257B (de) 1990-04-10
SE8601907L (sv) 1986-10-26
IT1215651B (it) 1990-02-22
FI83316C (fi) 1991-06-25
DK80291D0 (da) 1991-04-30
ES8801829A1 (es) 1988-02-16
SE461468B (sv) 1990-02-19
ES8802521A1 (es) 1988-07-16
CH675722A5 (de) 1990-10-31
DK165249B (da) 1992-10-26
DK164868C (da) 1993-01-11
DK190986D0 (da) 1986-04-24
ATA112186A (de) 1989-09-15
FI861684A0 (fi) 1986-04-22
YU46054B (sh) 1992-12-21
DK81091D0 (da) 1991-05-01
KR860008177A (ko) 1986-11-12
SU1450746A3 (ru) 1989-01-07
IT8620206A0 (it) 1986-04-24
ES8708229A1 (es) 1987-10-01
ES557552A0 (es) 1988-07-16
US4668686A (en) 1987-05-26
HU195813B (en) 1988-07-28
SU1470192A3 (ru) 1989-03-30
YU116787A (en) 1988-04-30
FR2581065A1 (fr) 1986-10-31
NO163406C (no) 1990-05-23
KR940000828B1 (ko) 1994-02-02
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
AU592983B2 (en) 1990-02-01

Similar Documents

Publication Publication Date Title
GB2174987B (en) Imidazoquinoline derivatives
EP0191562A3 (en) Tetrahydrocarbazolone derivatives
GB8620638D0 (en) Derivatives
GB8601292D0 (en) 13beta-alkylmilbemycin derivatives
GB8617292D0 (en) Poly-4-aminopyyrrole-2-carboxamido derivatives
GB8627491D0 (en) 5-phenyl-2-oxazole derivatives
GB2176181B (en) Aryltetralin derivatives
GB8614176D0 (en) Piperonylcarboxamido derivatives
GB2174703B (en) Pyridinylpiperazine derivatives
GB2172286B (en) Tetraprenylamine derivatives
GB2177692B (en) Diazinylpiperidine derivatives
GB8623513D0 (en) Glucosylmoranoline derivatives
GB8520631D0 (en) Derivatives
HK91289A (en) Bicyclocatechol derivatives
GB8511892D0 (en) Fluoralkane derivatives
GB2177695B (en) Aminoalkylamide derivatives
GB8600575D0 (en) Benzonorbornene derivatives
GB2177090B (en) 10-alpha-methoxy-6-methyl-ergoline derivatives
GB2174092B (en) Eburnamenine derivatives
GB8630780D0 (en) Estradiene derivatives
GB8531743D0 (en) 10beta-halo-alkynyl-estrene derivatives
GB8508422D0 (en) Punaglandin derivatives
IE850369L (en) Naphthyridine derivatives
GB8609591D0 (en) Pyridazodiazepine derivatives
GB8527320D0 (en) Flavolignan derivatives